Fund moves
2.9MShares reported
2 tracked managers disclosed the same change for Q3 2025. Among this manager's largest new positions for Q3 2025.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 6, 2025 · Filed Oct 15, 2025
A major shareholder of Spruce Biosciences sold $4.5K of Spruce Biosciences shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$4,484
Shares × reported transaction price
53 days after results of Aug 14, 2025, 35 days before results of Nov 10, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $130.40 on Oct 6, 2025, at its 52-week high
52-week range $4.50 (Jun 9, 2025) to $130.40 (Oct 6, 2025), 100% of the way up, from 228 adjusted closes. Describes the past only, not a forecast
RSI 97, 595% above its 200-day average, 1131% above its 50-day average, at the 52-week high, 20-day volatility 975% a year, against the S&P 500: +1345 points over 1 month
From the adjusted closes up to Oct 6, 2025. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −17.0% | +1.7% | −18.7% |
| 30 days | −30.5% | +0.8% | −31.3% |
| 90 days | −50.0% | +4.5% | −54.5% |
| 180 days | −56.7% | +5.1% | −61.8% |
| 365 days | −74.7% | +15.5% | −90.2% |
Past results only. Not a forecast.
Fund moves
2 tracked managers disclosed the same change for Q3 2025. Among this manager's largest new positions for Q3 2025.
Insider buying
Traded Oct 6, 2025 · filed 9 days later
A major shareholder of Spruce Biosciences paid $4.6K out of pocket for Spruce Biosciences shares.
Insider selling
Traded Oct 6, 2025 · filed 9 days laterNot reported under a pre-arranged trading plan
A major shareholder of Spruce Biosciences sold $436 of Spruce Biosciences shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.